Celldex Therapeutics
CLDX
#4692
Rank
โ‚น176.73 B
Marketcap
โ‚น2,660
Share price
6.44%
Change (1 day)
18.13%
Change (1 year)

Celldex Therapeutics (CLDX) Fails to deliver data

Key failure to deliver metrics for Celldex Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Celldex Therapeutics (CLDX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Celldex Therapeutics (CLDX) - since 2019

Volume in USD (price x number of shares), data since 2019

Celldex Therapeutics (CLDX) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025โ‚น11.28 M99.68%
2024โ‚น5.65 M43.21%
2023โ‚น3.94 M-85.8%
2022โ‚น27.79 M-36.31%
2021โ‚น43.63 M146.97%
2020โ‚น17.66 M1075.04%
2019โ‚น1.5 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Seagen
SGEN
N/Aโ‚น3.02 M๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚น0.39 Mโ‚น3.49 M๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น1.89 Mโ‚น4.32 M๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น5.75 Mโ‚น0.21 B๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น24.63 Mโ‚น0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น72.01 Mโ‚น0.40 B๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
โ‚น0.09 Mโ‚น0.36 M๐Ÿ‡บ๐Ÿ‡ธ USA